Abstract:
PURPOSE: A method and a kit for assessment of a neck skin age is provided to calculate the age of a neck skin by measuring a parameter including the skin color, winkle, elasticity of the neck skin. CONSTITUTION: In a method and a kit for assessment of a neck skin age, parameters including the skin color, winkle, elasticity of the neck skin are measured. The age of the neck skin is calculated from the measured parameter. The parameters are compared with the age of skin at ages. The grade level of individual parameter including the skin color, winkle, elasticity of the neck skin of a subject is measured. The grades of the measured individual parameters are compared with the age of the skin stored in a database.
Abstract:
PURPOSE: A composition containing medicinal herb extract is provided to promote adipocyte differentiation and to enhance anti-wrinkling, elasticity enhancement and anti-aging. CONSTITUTION: A composition for skin elasticity, anti-wrinkling, and anti-aging contains extract of Rehmannia glutinosa, Radix glycyrrhizae, Semen coicis, Fructus hordei, Fructus chaenomelis, Cortex acanthopanacis, and Radix puerariae as an active ingredient. An external use composition contains the extract as an active ingredient.
Abstract:
PURPOSE: An external use skin composition containing pine root extract is provided to remove free radical, to protect cellular membrane damage, and to suppress reactive oxygen species(ROS). CONSTITUTION: An external use skin composition contains pine root extract. The composition is used for anti-aging, and cell protection by promoting HSP70 generation. The external use skin composition contains 0.001-99 weight% of pine root extract based on total weight. The composition further contains cosmetically and dermatologically acceptable medium and/or substrate. The composition is used in the form of solution, gel, solid, emulsion, suspension, microemulsion, microcapsule, cream, skin, lotion, or spray. The composition is used for anti-aging and skin regeneration.
Abstract:
PURPOSE: A skin composition for external use containing Broussonetiae Fructus extract is provided to ensure skin barrier strengthening and skin moisturization and to be used in cosmetic products and in the medicinal field. CONSTITUTION: A composition for external use contains Broussonetiae Fructus extract as an active ingredient. The Broussonetiae Fructus extract enhances PPARs(peroxisome proliferator-activated receptors), fillatrin, trasglutaminase 1(TGase 1), or an hyaluronic acid synthase 1(HAS2) gene expression. The composition is used in the form of a lotion, eye cream, nutrition cream, massage cream, cleansing cream, cleansing foam, cleansing water, powder, essence, pack, or ointment.
Abstract:
PURPOSE: An external use skin composition for skin whitening containing natural products extract is provided to ensure skin whitening effect and melanogenesis suppression with stability to the skin. CONSTITUTION: An external use skin composition contains extract of Oldenlandia Diffusa Willd, Rheum undulatum LINNE, and Broussonetia kazinoki Sieb as an active ingredient. The extract of Oldenlandia Diffusa Willd, Rheum undulatum LINNE, and Broussonetia kazinoki Sieb is mixed in a weight ratio of 1-4:1-4:1-4.
Abstract:
PURPOSE: A mask pack composition for attachment is provided to improve skin elasticity and smooth skin wrinkle and enhance skin density of epidermal layer and dermal layer. CONSTITUTION: A mask pack composition for attachment contains red ginseng saponin, Camellia, Tussilago farfara L. extract, Mutabilis flower or Pomegranate extract. The composition contains 0.001-10 weight% of enzyme-treated red ginseng saponin. A mask pack for attachment is used in the form of wet type, cross-linking aqueous gel or non-cross linking aqueous gel.
Abstract:
3,5-Dihydroxy benzamide derivatives are provided to whiten the skin due to a depigmenting activity and improve stability in aqueous solution and organic solvent in formulation by inhibiting structure change. A cosmetic composition for whitening the skin comprises 0.01-20 wt.% of 3,5-dihydroxy benzamide derivatives represented by a formula(1), wherein a hydroxyl group is located in the 2,3-, 2,4-, 2,5-, 3,4- or 3,5-site, and is used in forms of emulsion, cream, cosmetic lotion, essence, pack, gel, powder, makeup base, foundation, lotion, ointment, patch, beauty solution, cleansing foam, cleansing cream, cleansing water, body lotion, body cream, body oil, body essence, shampoo, rinse, body cleanser, soap, hair dye or spray.
Abstract:
A hydroxamic acid derivative is provided to induce the activity increase of each promoter of IDH3alpha and CPT1 involving with energy consumption metabolism, thereby being usefully used for preventing or treating diseases related to dyslipidemia such as obesity, hyperlipidemia and diabetes. A hydroxamic acid is represented by a formula(1), wherein R1 is CONH, NHCO, CONR4 or NR4CO(where R4 is H or C1-10 alkyl); R2 is -(CH2)n-(where n is 0 or 1); and R3 is H or C1-10 alkyl. A method for preparing the hydroxamic acid comprises the steps of: (a) reacting an anhydrous compound synthesized by reacting ethyl chloroformate with piperonic acid using pyridine or N-methyl morpholine as a solvent with methyl 4-amino benzoate or 4-amino phenyl acetic acid ethyl ester at a temperature of 10-20 deg.C using pyridine or N-methyl morpholine as a solvent to prepare a benzamide compound; (b) reacting the benzamide with an alkyl halide selected from the group consisting of bromomethane, bromoethane, bromopropane, bromo isopropane, bromo butane, and bromo tert-butane to substitute an amide bond of the benzamide with an alkyl group; (c) hydrolyzing methyl ester in the benzamide obtained from the step(a) or the benzamide compound obtained from the step(b) to prepare an acid and reacting the acid with ethyl chloroformate using pyridine or N-methyl morpholine as a solvent to covert the acid into an anhydrous compound; and (d) reacting the anhydrous compound with hydroxyl amine chloride or N-methyl hydroxyl amine chloride at a temperature of 0-10 deg.C using pyridine or N-methyl morpholine as a solvent to obtain the product of the formula(1). An agent for anti-obese, treating diabetes or hyperlipidemia comprises the hydroxamic acid.